P-57 SUSCEPTIBILITY PATTERNS AND EMPIRICAL ANTIBIOTIC GUIDANCE FOR URINARY TRACT INFECTIONS IN PATIENTS WITH CIRRHOSIS

Conflict of interest: No Introduction and Objectives: The lack of data on bacterial susceptibility in urinary tract infections (UTI) among patients complicates empirical antibiotic selection. Aims: To assess the antibiotic susceptibility of UTI-causing bacteria in patients with cirrhosis and recomme...

Full description

Saved in:
Bibliographic Details
Main Authors: Carolina Vazquez, Gonzalo Gomez Perdiguero, Esteban Gonzalez Ballerga, Ilse Sorena Pardo Ivirico, Agustin Di Santo, Camila Maria Briz, Maria Dolores Murga, Ana Palazzo, Lorena Notari, Josefina Pages, Julia Brutti, Brenda Osso Sanchez, Manuel Mendizabal, Margarita Anders, Diego Giunta, Gisela Gualano, Agostina Romero, Alina Zerega, Pablo Calzetta, Martin Elizondo, Maria Laura Garrido, Maximiliano Castro, Astrid Smud, Jesica Milena Tomatis, Natalie J. Vilcinskas, Diego Arufe, Melisa Dirchowlf, Fernando Cairo, Nelly Gutierrez Acevedo, Adrian Gadano, Sebastian Marciano
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812400454X
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conflict of interest: No Introduction and Objectives: The lack of data on bacterial susceptibility in urinary tract infections (UTI) among patients complicates empirical antibiotic selection. Aims: To assess the antibiotic susceptibility of UTI-causing bacteria in patients with cirrhosis and recommend appropriate antibiotic therapy. Patients / Materials and Methods: Cross-sectional study using data from the prospective registry of bacterial infections in adult patients with cirrhosis in Argentina and Uruguay. We included episodes of culture-positive UTI in patients hospitalized for this condition or who developed a UTI during their stay. Antibiotic susceptibility patterns and recommendations are presented according to the site of acquisition. According to our definition, empirical antibiotic treatment should aim to cover roughly 80% of anticipated bacteria in stable patients and 90% in critically-ill patients. Results and Discussion: A total of 278 episodes were included, involving 227 patients recruited from 20 centers between Dec/2020 and July/2024. Of these, 97% (n=269) were monobacterial, and 3% (n=9) involved infections with two bacteria, resulting in 287 isolates. The most frequent isolates were enterobacteria, especially E. coli (43%), notably in community-acquired (CA) UTI (60%); K. pneumoniae accounted for 28% of the isolates, rising to 40% in nosocomial UTI. The most frequent Gram-positive cocci was enterococcus (14%). The table displays the susceptibility patterns for various antibiotics and highlights those suitable for empirical treatment according to the observed coverage. Multidrug resistance was observed in 52% (CI95: 46-58) of episodes: 40% (CI95: 32-50) in community-acquired and 68% (CI95: 57-77) in nosocomial infections. It is concerning that half of UTI are caused by multidrug-resistant organisms, and that only combinations of broad-spectrum antibiotics offer adequate coverage for nosocomial infections. Conclusions: For the first time in Latin America, we provide high-quality data to guide empirical antibiotic recommendations for UTI in patients with cirrhosis.
ISSN:1665-2681